Abstract
Purpose of review
The purpose of this review is to summarize how “-omics” technologies can inform rehabilitation-relevant outcomes for a range of populations with neurologically related disability by including outcome metrics linked to the World Health Organization’s International Classification of Functioning, Disability, and Health (WHO-ICF) domains of impairments in body function, activity limitations, and participation restrictions.
Recent findings
To date, nearly every area of medicine uses biomarkers in some capacity to aid in understanding how personal biology informs clinical care. “-Omics”-based approaches use high throughput genomics, proteomics, and transcriptomics assay platforms to tailor and personalize treatments for subgroups of similar individuals based on these results. The recent Precision Medicine Initiative (PMI), sponsored by the National Institutes of Health (NIH), has propelled biomarker-based and genomics research to the forefront of many translational research and care programs addressing a variety of medical populations. Yet, the literature is sparse on precision medicine approaches for those with neurologically related and other disability.
Summary
We demonstrate how the Rehabilomics Research model represents a translational framework for programs of precision rehabilitation research and care focused on linking personal biology to the biopsychosocial constructs that represent the WHO-ICF model and multidimensional outcome. We provide multiple exemplars from our own research program involving individuals with moderate-to-severe traumatic brain injury (TBI) to demonstrate how genomics and other biomarkers can be identified and assessed for their capacity to assist with personalized (precision) neurorehabilitation care and management.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
•• Committee NMRC. National Institutes of Health research plan on rehabilitation. [miscellaneous article]. J Phys Med. 2017;96 This reference provides specific priority areas delineated as relevant for NIH funded rehabilitation research
•• Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793–5. This article outlines the history and vision of the NIH Funded Precision Medicine Initiative
Lee MV, Katabathina VS, Bowerson ML, Mityul MI, Shetty AS, Elsayes KM, et al. BRCA-associated cancers: role of imaging in screening, diagnosis, and management. Radiogr Rev Publ Radiol Soc N Am Inc. 2017; 160144.
Hollis RL, Churchman M, Gourley C. Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer. Onco Targets Ther. 2017;10:2539–51.
CDC Press Releases [Internet]. CDC. [cited 2017 Apr 6]. Available from: http://www.cdc.gov/media/releases/2015/p0730-us-disability.html 2016.
•• Disability impacts all of us infographic | Disability and health | NCBDDD | CDC [Internet]. [cited 2017 Apr 6]. Available from: https://www.cdc.gov/ncbddd/disabilityandhealth/infographic-disability-impacts-all.html. This reference provides statistics on disability in the USA and its associated health burden.
naricspotlight. NIDILRR seeks comment on draft long-range plan [Internet]. Collect. Spotlight Natl. Rehabil. Inf. Cent. 2017 [cited 2017 Jun 15]. Available from: https://naricspotlight.wordpress.com/2017/01/19/nidilrr-seeks-comment-on-draft-long-range-plan/
•• WHO | International Classification of Functioning, Disability and Health (ICF) [Internet]. WHO. [cited 2013 Sep 30]. Available from: http://www.who.int/classifications/icf/en/. This reference outlines the WHO-ICF framework elements including body functions, activities, and participation as well as the role of personal and environmental factors on these endpoints.
Wagner AK. TBI translational rehabilitation research in the 21st century: exploring a rehabilomics research model. Eur J Phys Rehabil Med. 2010;46:549–56.
Wagner AK. Rehabilomics: a conceptual framework to drive biologics research. PM R. 2011;3:S28–30.
Wagner AK, Zitelli KT. A rehabilomics focused perspective on molecular mechanisms underlying neurological injury, complications, and recovery after severe TBI. Pathophysiol Off J Int Soc Pathophysiol ISP. 2013;20:39–48.
•• Wagner AK, Sowa G. Rehabilomics research: a model for translational rehabilitation and comparative effectiveness rehabilitation research. Am J Phys Med Rehabil Assoc Acad Physiatr. 2014;93:913–6. This reference describes the rehabilomics research model and its applicability to comparative effectiveness research design.
•• Wagner AK. A rehabilomics framework for personalized and translational rehabilitation research and care for individuals with disabilities: perspectives and considerations for spinal cord injury. J Spinal Cord Med. 2014;37:493–502. This reference provides a detailed overview of the Rehabilomics Research Framework, its application to TBI, and its applicability to SCI rehabilitation research.
Pistarini C, Aiachini B, Coenen M, Pisoni C. Italian network. Functioning and disability in traumatic brain injury: the Italian patient perspective in developing ICF Core sets. Disabil Rehabil. 2011;33:2333–45.
Ptyushkin P, Vidmar G, Burger H, Marincek C. Use of the International Classification of Functioning, Disability and Health (ICF) in patients with traumatic brain injury. Brain Inj. BI. 2010;24:1519–27.
Basch E, Artz D, Dulko D, Scher K, Sabbatini P, Hensley M, et al. Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23:3552–61.
Bock M, Moore D, Hwang J, Shumay D, Lawson L, Hamolsky D, et al. The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors. Breast Cancer Res Treat. 2012;134:1327–35.
Salaffi F, Stancati A, Procaccini R, Cioni F, Grassi W. Assessment of circadian rhythm in pain and stiffness in rheumatic diseases according the EMA (ecologic momentary assessment) method: patient compliance with an electronic diary. Reumatismo. 2005;57:238–49.
Johannes MS, Bigelow JD, Burck JM, Harshbarger SD, Kozlowski MV, van Doren T. An overview of the developmental process for the modular prosthetic limb. Johns Hopkins APL Tech Dig. 2011;30:207–16.
•• Juengst SB, Graham KM, Pulantara IW, McCue M, Whyte EM, Dicianno BE, et al. Pilot feasibility of an mHealth system for conducting ecological momentary assessment of mood-related symptoms following traumatic brain injury. Brain Inj. 2015;29:1351–61. His article begins to address compliance, accuracy, and satisfaction using EMA in a community-dwelling population with TBI.
Juengst SB, Terhorst L, Arenth PM, Wagner AK. Variability in emotional symptoms and fatigue measured via mobile ecological momentary assessment after TBI. 2017; Accepted ACRM.
Fleming J, Tooth L, Hassell M, Chan W. Prediction of community integration and vocational outcome 2-5 years after traumatic brain injury rehabilitation in Australia. Brain Inj. BI. 1999;13:417–31.
Juengst S, Skidmore E, Arenth PM, Niyonkuru C, Raina KD. Unique contribution of fatigue to disability in community-dwelling adults with traumatic brain injury. Arch Phys Med Rehabil. 2013;94:74–9.
Cifu DX, Keyser-Marcus L, Lopez E, Wehman P, Kreutzer JS, Englander J, et al. Acute predictors of successful return to work 1 year after traumatic brain injury: a multicenter analysis. Arch Phys Med Rehabil. 1997;78:125–31.
Yasuda S, Wehman P, Targett P, Cifu D, West M. Return to work for persons with traumatic brain injury. Am J Phys Med Rehabil Assoc Acad Physiatr. 2001;80:852–64.
Juengst S. Self Awareness and Community Integration after Traumatic Brain Injury [Internet]. 2013 [cited 2017 Jun 15]. Available from: http://d-scholarship.pitt.edu/16128/
Bombardier CH, Fann JR, Temkin NR, Esselman PC, Barber J, Dikmen SS. Rates of major depressive disorder and clinical outcomes following traumatic brain injury. JAMA. 2010;303:1938–45.
Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617–27.
Koponen S, Taiminen T, Portin R, Himanen L, Isoniemi H, Heinonen H, et al. Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study. Am J Psychiatry. 2002;159:1315–21.
Levin RL, Heller W, Mohanty A, Herrington JD, Miller GA. Cognitive deficits in depression and functional specificity of regional brain activity. Cogn Ther Res. 2007;31:211–33.
Juengst SB, Skidmore E, Wagner A. Behavioral changes and depression, disability, and life satisfaction in two cohorts of adults with TBI. Arch Phys Med Rehabil. 2014;95:e71.
Sabaz M, Simpson GK, Walker AJ, Rogers JM, Gillis I, Strettles B. Prevalence, comorbidities, and correlates of challenging behavior among community-dwelling adults with severe traumatic brain injury: a multicenter study. J Head Trauma Rehabil. 2014;29:E19–30.
Kelly G, Brown S, Todd J, Kremer P. Challenging behaviour profiles of people with acquired brain injury living in community settings. Brain Inj. 2008;22:457–70.
Arciniegas DB, Wortzel HS. Emotional and behavioral dyscontrol after traumatic brain injury. Psychiatr Clin North Am. 2014;37:31–53.
Brenner LA, Homaifar BY, Adler LE, Wolfman JH, Kemp J. Suicidality and veterans with a history of traumatic brain injury: precipitants events, protective factors, and prevention strategies. Rehabil Psychol. 2009;54:390–7.
Hesdorffer DC, Rauch SL, Tamminga CA. Long-term psychiatric outcomes following traumatic brain injury: a review of the literature. J Head Trauma Rehabil. 2009;24:452–9.
Homaifar BY, Brenner LA, Forster JE, Nagamoto H. Traumatic brain injury, executive functioning, and suicidal behavior: a brief report. Rehabil. Psychol. 2012;57:337–41.
Reeves RR, Laizer JT. Traumatic brain injury and suicide. J Psychosoc Nurs Ment Health Serv. 2012;50:32–8.
Simpson GK, Tate RL. Preventing suicide after traumatic brain injury: implications for general practice. Med J Aust. 2007;187:229–32.
Wasserman L, Shaw T, Vu M, Ko C, Bollegala D, Bhalerao S. An overview of traumatic brain injury and suicide. Brain Inj. BI. 2008;22:811–9.
Harrison-Felix CL, Whiteneck GG, Jha A, DeVivo MJ, Hammond FM, Hart DM. Mortality over four decades after traumatic brain injury rehabilitation: a retrospective cohort study. Arch Phys Med Rehabil. 2009;90:1506–13.
Teasdale TW, Engberg AW. Suicide after traumatic brain injury: a population study. J Neurol Neurosurg Psychiatry. 2001;71:436–40.
Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989;56:267–83.
Juengst SB, Myrga JM, Fann JR, Wagner AK. Cross-lagged panel analysis of depression and behavioral dysfunction in the first year after moderate-to-severe traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2017; appineuropsych16100217.
•• Myrga JM, Failla MD, Ricker JH, Dixon CE, Conley YP, Arenth PM, et al. A dopamine pathway gene risk score for cognitive recovery following traumatic brain injury: methodological considerations, preliminary findings, and interactions with sex. J Head Trauma Rehabil. 2016;31:E15–29. This article demonstrates the value of a gene risk score to capture genetic influence within a neurotransmitter pathway on cognitive performance after TBI
•• Myrga JM, Juengst SB, Failla MD, Conley YP, Arenth PM, Grace AA, et al. COMT and ANKK1 genetics interact with depression to influence behavior following severe TBI an initial assessment. Neurorehabil Neural Repair. 2016;30:920–30. This article demonstrates initial evidence that dopamine genetic variation influences behavioral symptoms after TBI. It also highlights how other personal factors (e.g., concurrent depression status) can influence genetic relationships
Failla MD, Myrga JM, Ricker JH, Dixon CE, Conley YP, Wagner AK. Posttraumatic brain injury cognitive performance is moderated by variation within ANKK1 and DRD2 genes. J Head Trauma Rehabil. 2015;30:E54–66.
Markos SM, Failla MD, Ritter AC, Dixon CE, Conley YP, Ricker JH, et al. Genetic variation in the vesicular monoamine transporter: preliminary associations with cognitive outcomes after severe traumatic brain injury. J Head Trauma Rehabil. 2017;32:E24–34.
McAllister TW, Flashman LA, Harker Rhodes C, Tyler AL, Moore JH, Saykin AJ, et al. Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study. Brain Inj BI. 2008;22:705–14.
Yue JK, Pronger AM, Ferguson AR, Temkin NR, Sharma S, Rosand J, et al. Association of a common genetic variant within ANKK1 with six-month cognitive performance after traumatic brain injury. Neurogenetics. 2015;16:169–80.
Jacobs E, D’Esposito M. Estrogen shapes dopamine-dependent cognitive processes: implications for women’s health. J Neurosci. 2011;31:5286–93.
Hygen BW, Belsky J, Stenseng F, Lydersen S, Guzey IC, Wichstrøm L. Child exposure to serious life events, COMT, and aggression: testing differential susceptibility theory. Dev Psychol. 2015;51:1098–104.
Barton D, Kumar R, Arenth P, Galang G, Berga S, Wagner A. Persistent hypogonadotropic hypogonadism: persistent hypogonadotropic hypogonadism in men after severe traumatic brain injury: temporal hormone profiles and outcome prediction. Am J Phys Med Rehabil. 2015;94:14.
•• Failla MD, Juengst SB, Arenth PM, Wagner AK. Preliminary associations between brain-derived neurotrophic factor, memory impairment, functional cognition, and depressive symptoms following severe TBI. Neurorehabil Neural Repair. 2016;30:419–30. This work shows how chronic neurotrophin physiology may influence risk for long-term impairments, in this case memory impairments.
•• Juengst SB, Kumar RG, Failla MD, Goyal A, Wagner AK. Acute inflammatory biomarker profiles predict depression risk following moderate to severe traumatic brain injury. J Head Trauma Rehabil. 2015;30:207–18. This work shows how the acute inflammatory response may influence risk for mental health impairments, in this case depressive symptoms.
Juengst SB, Kumar RG, Arenth PM, Wagner AK. Exploratory associations with tumor necrosis factor-α, disinhibition and suicidal endorsement after traumatic brain injury. Brain Behav Immun. 2014;41:134–43.
Barton DJ, Schuster AA, Oh B-M, Juengst SB, Kumar RG, Wagner AK. Long-term cognitive outcomes associated with acute cortisol levels after moderate to severe TBI. J Neurotrauma. 2016;33
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The author declares no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any original research studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical collection on Neurotrauma
Rights and permissions
About this article
Cite this article
Wagner, A.K. TBI Rehabilomics Research: an Exemplar of a Biomarker-Based Approach to Precision Care for Populations with Disability. Curr Neurol Neurosci Rep 17, 84 (2017). https://doi.org/10.1007/s11910-017-0791-5
Published:
DOI: https://doi.org/10.1007/s11910-017-0791-5